GRCL Aset Perusahaan Gracell Biotechnologies Ltd

GRCL (Gracell Biotechnologies Ltd) - tandha merek perusahaan

The field of oncology treatment via cell therapy remains entirely decoupled from market volatility, as evidenced by the price history on the total assets chart at GURU.Markets, where the indicator stands at 258.96. Within the framework of ESG standards, Gracell Biotechnologies (GRCL) is implementing eco-friendly recycling in its laboratories. High demand for rapid blood cancer treatment methods has led to the merger of Gracell Biotechnologies (GRCL) with a global pharmaceutical behemoth.

GRCL - Total Aset Perusahaan Gracell Biotechnologies Inc. ing rentang 04.07.2022 - 03.03.2024

Rincian analitis lan laporan data perusahaan Gracell Biotechnologies Ltd (GRCL)

- rega saham lan konsensus proyeksi valuasi:
Bagan rega gracellbio.com|GRCL - Bagan rega target
- data kapitalisasi pasar:
Nilai pasar Gracell|GRCL - Nilai Total Perusahaan
- data ekuitas miturut neraca:
Ekuitas saben Saham Gracell Biotechnologies|GRCL - Kapitalisasi Buku|Rasio Kapitalisasi marang Aset Bersih gracellbio.com|GRCL - Aset Agregat Perusahaan
- rincian utang lan likuiditas:
Utang marang Modal Gracell Biotechnologies|GRCL - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Gracell|GRCL - Utang perusahaan|Utang-utang marang nilai buku Gracell|GRCL - Utang jangka dawa perusahaan|Tanggungan jangka cendhak Gracell Biotechnologies|Likuiditas darurat gracellbio.com
- statistik bathi lan rasio pasar:
GRCL - Penghasilan resik
Analisis dhasar perusahaan:GRCL gracellbio.com
Produk mawa merek Gracell

This metric reflects the market consensus regarding the company's total resources and liabilities, calculated inversely via return on assets (ROA) to identify hidden valuation imbalances. An analysis of total balance sheet assets allows for an assessment of how the FasTCAR technology stack and integration into biopharmaceutical supply chains convert into asset capitalization, confirming the fundamental stability of Gracell Biotechnologies (GRCL) while scaling CAR-T cell production.

Pesaing langsung

LEGN (legendbiotech.com) - Aset Agregat Perusahaan|Aset Agregat Perusahaan Sana Biotechnology, Inc.|Aset Perusahaan Autolus Therapeutics PLC AUTL|Aset Agregat Perusahaan Allogene Therapeutics Inc (ALLO)|Selecta Biosciences Inc. - Total Aset Bisnis|Total Aset Perusahaan CLLS (Cellectis)|CRBU - Gunggung Aset Perusahaan|TIL - Aset Agregat Perusahaan|Aset Perusahaan Genenta Science S.p.A.|centurytx.com (IPSC) - Aset Agregat Perusahaan|JSPR (Jasper Therapeutics, Inc.) - Aset Agregat Perusahaan|Aset Agregat Perusahaan Senti Bio|Aset Perusahaan Adaptimmune Therapeutics PLC ADAP|Total Aset Perusahaan CERO|alaunos.com (TCRT) - Aset Neraca Perusahaan|Achilles Therapeutics plc - Gunggung Aset Perusahaan|CARGO Therapeutics, Inc (CRGX) - Aset Perusahaan|PSTX: Gunggung Aset Perusahaan|Nilai Agregat Aset TSVT (2seventybio.com)